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Sexual dysfunction in patients with psoriasis 
and psoriatic arthritis − a systematic review
Patricia Shu Kurizky1, Licia Maria Henrique da Mota2
ABSTRACT
Psoriasis is a cutaneous-articular disease, whose incidence ranges from 1% to 3%. Stress tends to be a triggering or ag-
gravating factor in psoriasis. In addition, the disease itself can generate emotional stress because of its lesions. Several 
psychological disorders can be associated with psoriasis, and feelings such as rage, depression, shame, and anxiety have 
been commonly reported, which can culminate in social isolation and sexual dysfunction. Despite being a common 
complaint among patients with psoriasis, sexual dysfunction has been rarely reported in the literature. This study aimed 
at performing a systematic review of the prevalence of sexual dysfunction in psoriasis and psoriatic arthritis, assessing 
the role played by factors such as depression and severity of disease in this relation. This systematic review showed 
that data on the sexual diffi culties of patients with psoriasis are scarce. The hypotheses to explain sexual dysfunction 
in that group of patients include the severity of skin fi ndings, the psychological effects of the condition on the patient, 
concerns of the sexual partner, and side effects of the medical treatments for psoriasis. Those data emphasize that this 
type of symptomatology is frequently neglected in medical practice, and stress the importance of assessing the impact of 
psoriasis regarding not only cutaneous and joint involvements, but also psychosocial and sexual impairments. Considering 
the sociocultural diversities of each population, a specifi c study of the Brazilian population to provide more information 
about our patients is required. 
Keywords: psoriasis, psoriatic arthritis, gender, sexuality.
© 2012 Elsevier Editora Ltda. All rights reserved.
INTRODUCTION
Psoriasis is a recurring, cutaneous-articular, chronic infl ammatory 
disease, resulting from immune and proliferative changes that af-
fect the skin and, sometimes, the mucosae. Its world incidence is 
estimated to be 1%–3%.1−3 In 5%−42% of the patients, the skin 
fi ndings are associated with infl ammatory arthritis, usually negative 
for  rheumatoid factor, a condition denominated psoriatic arthritis.4,5 
Stress tends to be a triggering or aggravating factor in 
psoriasis. In addition, the disease itself can generate emotional 
stress because of its lesions.6 Several psychological disorders 
can be associated with psoriasis, and feelings such as rage, 
depression, shame and anxiety have been commonly reported, 
which can culminate in social isolation and higher consumption 
of alcohol and tobacco.7−11 
According to the World Health Organization, sexuality is a 
basic need and an aspect of human beings that cannot be sepa-
rated from others,12 extremely important in maintaining good 
mental health. The impact of psoriasis on sexual functioning is 
signifi cant, because the condition causes intense interpersonal 
strain, hindering quality of life.
Sexual impotence and erectile dysfunction due to the 
medicamentous therapy for the disease, such as etretinate and 
methotrexate, have been reported.13−15 However, few studies 
have directly related sexual dysfunction to psoriasis.16,17 
Systematic reviews of prevalence studies are important 
because they provide useful information regarding both medi-
cal practice and research projects. A deep view of the study’s 
design and methodology applied to data collection is funda-
mental to planning future studies. 
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This study aimed at performing a systematic review of the 
studies on sexual dysfunction of patients with psoriasis and 
psoriatic arthritis, assessing aspects commonly identifi ed as as-
sociated, such as psychological problems and disease severity. 
METHODS
From August to October 2011, searches were performed within the 
following databases in Portuguese, English, French and Spanish: 
Medline (1966−2011); Cochrane Library; LILACS; PubMed 
(1991−2011); and Scopus. The following keywords were used: 
“psoriasis”; “sexual dysfunction”; and “psoriatic arthritis”.
Cross-sectional observational studies, prospective cohorts, 
randomized controlled studies, and case-control studies about 
the sexual function of patients with psoriasis and/or psoriatic 
arthritis were included. 
The title and abstract of the articles obtained in the initial 
search were reviewed by two independent observers to iden-
tify the relevant articles. The full text of all articles meeting 
the inclusion criteria was reviewed, and their bibliographic 
references were assessed in the search for additional sources. 
The articles upon which the two observers had agreed were 
considered for the analysis.
From the studies selected, the following data were as-
sessed: type of study; sample size; instruments used; statistical 
analysis; and results.
RESULTS
Of the articles identifi ed in the databases cited, only 14 related 
directly to the topic investigated. Of those 14, seven were 
excluded because they were either case reports or review 
articles. In addition to the remaining seven articles, one more 
was identifi ed in the assessment of the bibliographic references, 
adding up to a total of eight articles selected.
Of the eight articles selected, three were of the case-control 
type, and fi ve were observational cross-sectional studies. 
Neither randomized controlled studies, nor prospective cohort 
studies, were found. Regarding the three case-control studies, 
two have compared men and women with psoriasis to healthy 
individuals,18,19 and one has compared men with psoriasis with 
men with other dermatological diseases.20 All observational 
studies have included patients of both sexes. Table 1 shows 
the types of studies and the samples assessed.
A total of 4,039 patients with psoriasis was assessed, of 
whom 2,567 were men (63.55%) and 1,472, women (36.45%). 
Those patients’ ages ranged from 23–62 years. Table 2 shows 
the epidemiological characteristics of the samples of each study.
The severity of psoriasis has been assessed by dermatolo-
gists based on the Psoriasis Area and Severity Index (PASI) in 
three studies19,21,22 and on the Total Body Surface Area (BSA) 
in one study,23 and by patients by use of the Self-Administered 
Table 1 
Types of studies and samples assessed
Author Publication year Study design Patients Controls
Mercan18 2008 Case-control 24 33
Al-Mazeedi21 2006 Observational 330 —
Meeuwis24 2011 Observational 487 —
Sampogna2 2006 Observational 936 —
Ermertcan19 2006 Case-control 78 58
Gupta23 1997 Observational 120 —
Goulding20 2011 Case-control 92 130
Guenther22 2011 Observational 1996 —
Table 2 
Epidemiological characteristics of the samples studied
Author
Psoriasis - number Control - number Psoriasis - age Control - age
Men Women Men Women Men Women Men Women
Mercan18 Number according to gender not defi ned 37.29 ± 11.27 36.09 ± 7.97
Al-Mazeedi21 169 161 — 32−35 —
Meeuwis24 278 209 — 53.9 ± 12.3 —
Sampogna2 555 381 — 45.7 —
Ermertcan19 39 39 31 27 22.33−59.31 23.21−49.44 41.77 ± 9.60 39.89 ± 9.06
Gupta23 63 57 — 46.8 ± 15.7 —
Gouldin20g 92 — 130 — 46.7 ± 13.1 — 52.7 ± 17.2 —
Guenther22 1371 625 — 46 —
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Psoriasis Area and Severity Index (SAPASI) in two studies.2,24 
Two studies have not assessed the extent of psoriasis.18,20 The 
presence of genital lesions2,20,23,24 and the involvement of 
joints2,22−24 have been reported in four studies.
All studies have assessed the sexual function by means of 
self-administered questionnaires, and some studies have also as-
sessed psychological aspects and quality of life. The most often 
used questionnaires to assess sexual function were as follows: the 
Dermatology Life Quality Index (DLQI), Question #9 (Over the 
last week, how much has your skin caused any sexual diffi culties 
− not at all, a little, a lot, very much);2,19,22,24 the International 
Index of Erectile Function (IIEF);19,20,24 and the Female Sexual 
Function Index (FSFI).19,24 Gupta et al.23 have elaborated and 
used their own questionnaire, and Ermertcan et al.19 have elabo-
rated a questionnaire based on questions about sexual health 
extracted from several quality of life questionnaires, such as 
Skindex-29, DLQI, Psoriasis Disability Index (PDI), and Impact 
of Psoriasis on Quality of Life (IPSO) questionnaire. Table 3 
shows the instruments used by each author.
Quality of life, depression and sexual function
In the study by Mercan et al.,18 sexual dysfunction was more 
common in the group of patients with psoriasis than in the 
control group, and statistically signifi cant difference (P < 0.05) 
was observed between the orgasmic experience total score and 
subscore of the Arizona Sexual Experience Scale (ASEX). 
Ten patients of the psoriasis group had BDI score > 17, being 
considered clinically depressed. After their exclusion, ANOVA 
and Tuckey test in the two groups showed similar results of 
ASEX score.
Al-Mazeedi et al.21 have reported a greater prevalence of 
psychological disorders in the severe psoriasis group. The sex-
ual activity was affected in 31.6% of the patients. Dysfunction 
was identifi ed in 38.9% of the patients with severe psoriasis, 
in 29.7% of those with moderate psoriasis, and in 30.8% of 
those with mild psoriasis. The difference between the groups, 
however, was not statistically signifi cant. 
The study by Meeuwis et al.24 has focused mainly on the 
presence of genital psoriasis. The mean total score of DLQI 
was 6.6 ± 5.5. Patients with genital lesions scored worse than 
those without genital lesions, especially in the question refer-
ring to sexual life. 
Using the Sexual Quality of Life Questionnaire for Men 
(SQoL-M), men with psoriasis scored 77.2 ± 24.1 (the index 
ranges from 0 to 100, and the higher the score, the better the 
quality of sexual life); when using the IIEF, their score was 
55.7 ± 17.2 (the index ranges from 5–75, and the higher the 
score, the better the sexual function), with no statistically 
signifi cant difference between the groups with and without 
genital lesion. Regarding women, 37.7% had a Female Sexual 
Table 3 
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Guenther22 DLQI Question #9 Sexual function
ASEX: Arizona Sexual Experience Scale; BDI: Beck Depression Inventory; DQoLS: Dermatology Quality of Life Scale; DLQI: Dermatology Life Quality Index; SQoL-M: Sexual Quality of Life Questionnaire for Men; 
IIEF: International Index of Erectile Function; FSDS: Female Sexual Distress Scale; FSFI: Female Sexual Function Index; PDI: Psoriasis Disability Index; IPSO: Impact of Psoriasis on Quality of Life Questionnaire; 
GHQ-12: General Health Questionnaire.
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Distress Scale (FSDS) score > 15, evidencing an alteration in 
sexual life. The mean score of women with genital lesions was 
signifi cantly higher than that of those without genital lesions. 
Regarding FSFI, 48.7% of the women scored < 26, indicating 
sexual dysfunction. That alteration was equally distributed 
among women with and without genital lesions.
Sampogna et al.2 have reported that 48.2% of their patients 
could be characterized as having minor psychological disorders 
(depression and anxiety). The prevalence of sexual dysfunc-
tion varied according to the question analyzed, from 35.5% 
with the PDI question to 71.3% with the IPSO question. The 
prevalence was higher among patients with psoriatic arthritis, 
psychological disorders and SAPASI scores > 20 in all ques-
tions. Regarding the IPSO question, the prevalence of sexual 
dysfunction was higher among women.
In the study by Ermertcan et al.,19 the patients were divided 
into six groups as follows: female and male healthy controls; 
female and male psoriasis groups without depression; and 
female and male psoriasis groups with depression. The mean 
PASI among women without depression was 6.53 ± 4.25, and 
among those with depression, 6.54 ± 6.96. The DLQI showed 
a more signifi cant worsening of quality of life in the group 
with depression as compared with that without depression. 
The FSFI total score showed signifi cant sexual dysfunction 
in the groups with psoriasis with and without depression as 
compared with the control group. However, no statistically 
signifi cant difference was observed between the two groups 
with psoriasis. When the domains were assessed separately, 
the scores of all domains, except for lubrication and pain, were 
signifi cantly worse in the groups with psoriasis. A negative 
correlation was observed between the FSFI and DLQI scores, 
but PASI showed no correlation.
Regarding the male groups, the mean PASI was 9.27 ± 6.03 
in those with psoriasis alone, and 7.31 ± 4.51 in those with pso-
riasis and depression. The DLQI total score was signifi cantly 
higher in patients with psoriasis and depression when compared 
with those without depression, characterizing worse quality 
of life. The IIEF total score showed signifi cant dysfunction in 
the groups with psoriasis as compared with the control group, 
and no difference was observed between the two groups with 
psoriasis. When the domains were assessed separately, the 
satisfaction with sexual relationship was signifi cantly low in 
patients with psoriasis; the other domains were also lower, but 
with no statistically signifi cant difference. The IIEF total score 
showed correlation with neither PASI nor DLQI.
Gupta et al.23 have found that, of 120 patients studied, 49 
(40.8%) reported a decline in sexual activity after the onset 
of psoriasis. In the group with sexual dysfunction, 77% of 
the patients had joint pain as compared with 54% of those in 
the group without sexual dysfunction. The group with sexual 
dysfunction also had signifi cantly more depression and higher 
tendency towards alcohol consumption. The decline in sexual 
activity was associated with the effect of psoriasis on physical 
appearance by 60% of the patients, while 14.9% attributed it 
to decreased sex drive of their spouse/partner.  
The study by Goulding et al.20 has focused mainly on the 
presence of erectile dysfunction. The mean DLQI score was 
signifi cantly higher in the group with psoriasis. Of 92 individu-
als, 53 (58%) had an IIEF score ≤ 21, which indicates erectile 
dysfunction, which occurred in 64 of 120 controls (49%), 
showing no statistically signifi cant difference.
Guenther et al.22 have assessed the treatment with 
ustekinumab in 1,996 patients. Prior to treatment, 22.6% of 
the patients had sexual dysfunction, assessed based on DLQI 
Question #9. Sexual dysfunction was most frequent in women 
(27.1%) than in men (20.8%). The proportion of patients with 
sexual dysfunction was directly correlated with the PASI.
DISCUSSION
Data on the sexual diffi culties of patients with psoriasis are 
scarce. The hypotheses to explain sexual dysfunction in that 
group of patients include the severity of skin fi ndings, the 
psychological effects of the condition on patients, concerns of 
the sexual partner, and side effects of the medical treatments 
for psoriasis.22
Multiple studies have associated psoriasis with psycho-
logical morbidity, especially depression and anxiety.10,25,26 
Some authors have suggested that high levels of pro-infl am-
matory cytokines, specifi cally tumor necrosis factor alpha 
and interleukine 1, involved in the pathogenesis of psoriasis, 
are related to depression.27 Those psychological conditions 
were more prevalent in patients with psoriasis in four of the 
studies analyzed. 
A positive correlation between sexual dysfunction and 
depression has been reported in the studies by Mercan et al.,18 
Sampogna et al.,2 and Gupta et al.23 However, Mercan et al.18 
have observed that patients with psoriasis had more sexual 
disorders related to orgasm than to sexual drive. Because the 
sexual disorders of depression affect typically the sexual drive 
rather than orgasm itself, those authors have suggested that 
the sexual dysfunction in psoriasis might be related to other 
reasons than depression. Ermertcan et al.,19 comparing healthy 
individuals and individuals with psoriasis with and without 
depression, have found no correlation between psychological 
problems and presence of sexual dysfunction.
Kurizky et al.
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Regarding the clinical fi ndings, the severe/moderate form 
was more associated with sexual dysfunction in two studies,2,22 
but two other showed no statistically signifi cant difference.19,21 
The presence of psoriatic arthritis has been also related in two 
studies.2,23 The presence of genital lesion had an impact on qual-
ity of life, but showed no correlation with sexual function,2,19,20 
except in the study by Meeuwis et al.24 In that study, women 
with genital psoriasis had impaired sexual function, but that did 
not happen to the male group. The authors have suggested that 
the presence of the genital lesion itself might not be the cause of 
sexual function decline, but the patient’s subjective experience.
Except for the study by Goulding et al.,20 all others have 
shown a decline in the sexual function of patients with pso-
riasis. An explanation for that could be the fact that those 
authors have used in the control group individuals with other 
dermatological diseases, but including some conditions that can 
be extensive, with esthetic and physical limitations similar to 
those of psoriasis, such as atopic eczema and lupus erythema-
tosus. The authors have reported high prevalence of erectile 
dysfunction in the total sample studied (50%), corresponding 
to the population with dermatological diseases. In addition, 
sexual dysfunction has already been correlated with other 
skin conditions, such as sexually transmissible diseases,28,29 
vitiligo,30,31 chronic urticaria,31 and neurodermatitis.18,28 
Finally, it is worth noting the result reported by Meeuwis 
et al.,24 according to which only 9% of their patients were 
satisfi ed with the attention given by healthcare professionals 
to their sexual problems, while 43% perceived it as insuffi -
cient. Those data emphasize that this type of symptomatology 
is frequently neglected in medical practice,32 and stress the 
importance of assessing the impact of psoriasis regarding not 
only cutaneous and joint involvements, but also psychosocial 
and sexual impairments. 
During this study review, the association of the term 
“Brazil” in the database search identified no article. 
Considering the sociocultural diversities of each population, 
a specifi c study of the Brazilian population to provide more 
information about our patients is required. 
Disfunção sexual em pacientes com psoríase e artrite psoriásica − uma revisão sistemática
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